Lapol 30

Lansoprazole, the active ingredient in Lapol, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is employed in the management of acid‑related gastrointestinal disorders in adults and adolescents. GNH USA supplies Lapol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related conditions. - Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - Helicobacter pylori eradication therapy: enhances bacterial clearance when used with antibiotics.

Adverse reactions may occur with Lansoprazole therapy.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: watery stools, usually transient. - Nausea: occasional upset stomach. - Abdominal pain: cramp‑like discomfort. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent diarrhea, abdominal pain. - Liver enzyme elevation: signs of hepatic dysfunction. - Low magnesium levels: muscle cramps, irregular heartbeat. - Stevens‑Johnson syndrome: severe skin blistering. - Pancreatitis: upper abdominal pain, nausea, vomiting.

Before initiating Lansoprazole, consider the following safety measures. - Renal function assessment: adjust use in severe impairment. - Hepatic impairment evaluation: monitor for accumulation. - Elderly patients: start with lowest effective dose. - Concomitant medications: review drugs that require gastric acidity for absorption. - Infection monitoring: be alert for signs of C. difficile infection. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Lansoprazole may interact with several medicines; awareness helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Ketoconazole: markedly decreased antifungal absorption. - Atazanavir: reduced antiviral effectiveness. - Clarithromycin: increased risk of cardiac arrhythmias. - HIV protease inhibitors (e.g., ritonavir): diminished antiviral levels. - Warfarin: potential alteration of anticoagulant effect.

Moderate Interactions (Monitor Closely): - Clopidogrel: reduced antiplatelet activity. - Methotrexate: increased serum concentrations. - Digoxin: possible increase in serum levels. - Iron supplements: decreased iron absorption. - Vitamin B12: potential long‑term deficiency with prolonged use.